Page last updated: 2024-10-26

ethosuximide and Ache

ethosuximide has been researched along with Ache in 4 studies

Ethosuximide: An anticonvulsant especially useful in the treatment of absence seizures unaccompanied by other types of seizures.
ethosuximide : A dicarboximide that is pyrrolidine-2,5-dione in which the hydrogens at position 3 are substituted by one methyl and one ethyl group. An antiepileptic, it is used in the treatment of absence seizures and may be used for myoclonic seizures, but is ineffective against tonic-clonic seizures.

Research Excerpts

ExcerptRelevanceReference
"Ethosuximide was halted and due to the severe symptoms, treatment with both prednisolone and intravenous iloprost was commenced."5.72Severe Raynaud's phenomenon from ethosuximide raised concern over possible onset of systemic vasculitis: a case report. ( Berntson, L; Liminga, G, 2022)
" The initial anticonvulsant screening was performed in mice (ip) using the 'classical' maximal electroshock (MES) and subcutaneous pentylenetetrazole (scPTZ) tests as well as in the six-Hertz (6Hz) model of pharmacoresistant limbic seizures."3.83New hybrid molecules with anticonvulsant and antinociceptive activity derived from 3-methyl- or 3,3-dimethyl-1-[1-oxo-1-(4-phenylpiperazin-1-yl)propan-2-yl]pyrrolidine-2,5-diones. ( Abram, M; Andres-Mach, M; Kamiński, K; Obniska, J; Rapacz, A; Zagaja, M; Łuszczki, JJ, 2016)
"Ethosuximide was halted and due to the severe symptoms, treatment with both prednisolone and intravenous iloprost was commenced."1.72Severe Raynaud's phenomenon from ethosuximide raised concern over possible onset of systemic vasculitis: a case report. ( Berntson, L; Liminga, G, 2022)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's2 (50.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Yogeeswari, P1
Ragavendran, JV1
Sriram, D1
Nageswari, Y1
Kavya, R1
Sreevatsan, N1
Vanitha, K1
Stables, J1
Kamiński, K1
Zagaja, M1
Rapacz, A1
Łuszczki, JJ1
Andres-Mach, M1
Abram, M1
Obniska, J1
Berntson, L1
Liminga, G1
Palazzo, E1
Rimoli, MG1
De Chiaro, M1
Guida, F1
Melisi, D1
Curcio, A1
de Novellis, V1
Marabese, I1
Rossi, F1
Abignente, E1
Maione, S1

Other Studies

4 other studies available for ethosuximide and Ache

ArticleYear
Discovery of 4-aminobutyric acid derivatives possessing anticonvulsant and antinociceptive activities: a hybrid pharmacophore approach.
    Journal of medicinal chemistry, 2007, May-17, Volume: 50, Issue:10

    Topics: Analgesics; Animals; Anticonvulsants; Disease Models, Animal; gamma-Aminobutyric Acid; Hyperalgesia;

2007
New hybrid molecules with anticonvulsant and antinociceptive activity derived from 3-methyl- or 3,3-dimethyl-1-[1-oxo-1-(4-phenylpiperazin-1-yl)propan-2-yl]pyrrolidine-2,5-diones.
    Bioorganic & medicinal chemistry, 2016, Feb-15, Volume: 24, Issue:4

    Topics: Analgesics; Animals; Anticonvulsants; Disease Models, Animal; Dose-Response Relationship, Drug; Elec

2016
Severe Raynaud's phenomenon from ethosuximide raised concern over possible onset of systemic vasculitis: a case report.
    Pediatric rheumatology online journal, 2022, Dec-22, Volume: 20, Issue:1

    Topics: Child; Connective Tissue Diseases; Ethosuximide; Female; Fingers; Humans; Pain; Raynaud Disease; Sys

2022
Intra-periaqueductal grey microinjections of an imidazo[1,2-b]pyridazine derivative, DM2, affects rostral ventromedial medulla cell activity and shows antinociceptive effect.
    Neuropharmacology, 2010, Volume: 58, Issue:3

    Topics: Action Potentials; Analgesics; Animals; Anticonvulsants; Blood Pressure; Dose-Response Relationship,

2010